IPP Bureau
Philips reiterates FY25 outlook following steady Q3 performance
By IPP Bureau - November 07, 2025
Adjusted EBITDA increased by 12.3 per cent to $531 million, up from $516 million in the same period last year
Sovato secures series B funding to advance remote robotic surgery platform
By IPP Bureau - November 07, 2025
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Valneva’s next-gen Zika vaccine shows strong safety and immune response in phase I trial
By IPP Bureau - November 07, 2025
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
UPS acquires Andlauer for $1.6 billion to strengthen global healthcare network
By IPP Bureau - November 07, 2025
The integration of AHG’s specialized cold chain transportation and third-party logistics (3PL) solutions will significantly strengthen UPS Healthcare’s service offerings
Zydus receives FDA’s ODD for Desidustat for the treatment of beta-thalassemia
By IPP Bureau - November 06, 2025
Orphan drug designation (ODD) by the USFDA for Desidustat, provides eligibility for a potential seven-year marketing exclusivity subject to the USFDA approval
Senores Pharma forms new subsidiary in US
By IPP Bureau - November 06, 2025
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
Novo Nordisk presents four new analyses on oral semaglutide 25 mg at ObesityWeek 2025
By IPP Bureau - November 06, 2025
Oral semaglutide 25 mg was associated with the same weight loss efficacy in women with obesity regardless of menopausal stage, and patients reported improvements in physical function, respectively
Zydus wellness reports 31% growth in net sales in Q2 FY26
By IPP Bureau - November 06, 2025
During the quarter, Zydus Wellness completed the acquisition of Comfort Click Limited and its subsidiaries
EazeBio and UC Santa Cruz partner to advance instrument-free diagnostic platform
By IPP Bureau - November 06, 2025
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Cupid bags largest share in South Africa’s 5-year National Condom Program
By IPP Bureau - November 06, 2025
Cupid has been allocated approximately 23.4 million units of female condoms per year
Ginkgo Bioworks and Bayer renew partnership to power the next wave of Ag Biologicals
By IPP Bureau - November 06, 2025
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Sumitomo Pharma America unveils promising new leukemia and myelofibrosis data ahead of ASH 2025
By IPP Bureau - November 06, 2025
Enzomenib, an oral, small-molecule inhibitor designed to disrupt the menin-MLL protein interaction involved in leukemogenesis
RedHill secures final $10.5M court judgment for enforcement
By IPP Bureau - November 06, 2025
RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment
Eli Lilly to invest $1.2 billion in Puerto Rico to boost U.S. oral medicine production
By IPP Bureau - November 06, 2025
J&J MedTech reports strong one-year results for shockwave peripheral IVL system in DISRUPT BTK II trial
By IPP Bureau - November 06, 2025
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
